HÀ NỘI — Hậu Giang Pharmaceutical Joint Stock Company (DHG), Việt Nam’s largest publicly traded drug manufacturer, is planning a cash dividend payout of 35 per cent for 2016. The company also plans to issue bonus shares to raise capital from owners’ equity at a ratio of 2:1. Currently, Japanese drug manufacturer Taisho Pharmaceutical Company Limited is DHG’s largest foreign shareholder, with a 24.5 per cent stake. DHG intends to follow in the steps of Domesco (DMC) and make more room for foreign investors. Based in Cần Thơ Province since 1974, DHG is one of the leading drug manufacturers in the country.

Source: Viet Nam News March 28, 2017 11:01 UTC